GSK Avandamet Antidiabetic Combo Expected In Pharmacies In November
Executive Summary
GlaxoSmithKline's Avandamet combination rosiglitazone/metformin product for diabetes is expected to be available in November, the company said after Oct. 10 FDA approval
You may also be interested in...
Quarterly Call Round-Up: Pfizer, GSK, Lilly Updates
Pfizer sees more savings from Pharmacia: Pfizer is now projecting "at least" $1 bil. in synergies from the Pharmacia acquisition in 2003, indicating that it expects to exceed its original target of $1 bil. in first-year savings...
Quarterly Call Round-Up: Pfizer, GSK, Lilly Updates
Pfizer sees more savings from Pharmacia: Pfizer is now projecting "at least" $1 bil. in synergies from the Pharmacia acquisition in 2003, indicating that it expects to exceed its original target of $1 bil. in first-year savings...
Paxil OS GMP Concerns Resolved By Year-End, GSK Says After Warning Letter
GlaxoSmithKline expects to resolve GMP issues related to production of Paxil oral suspension at its Certenejas Cidra, Puerto Rico facility by the end of the month, the company said